Mustang Bio Inc (NASDAQ:MBIO)
| 1.98 Delayed Data As of 3:40pm ET |  +0.03 / +1.54%Today’s Change | 1.92 Today|||52-Week Range 11.08 | -66.57% Year-to-Date |
Latest MBIO News | Press Releases
No recent news for Mustang Bio Inc.
Today’s Trading
| Previous close | 1.95 |
| Today’s open | 2.01 |
| Day’s range | 1.97 - 2.01 |
| Volume | 185 |
| Average volume (3 months) | 40,796 |
| Market cap | $16.5M |
Data as of 3:40pm ET, 10/04/2023
Growth & Valuation
| Earnings growth (last year) | +0.75% |
| Earnings growth (this year) | +38.51% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 0.31 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| AYTUAytu Biopharma Inc | +0.04 | +1.37% |
| ---- | ||
| LPCNLipocine Inc | -0.10 | -3.42% |
| ACORAcorda Therapeutics ... | -0.13 | -1.04% |
Data as of 3:59pm ET, 10/04/2023
Financials
| Next reporting date | November 14, 2023 |
| EPS forecast (this quarter) | -$1.58 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$77.5M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Worcester, Massachusetts |
Forecasts
